Camp4 Therapeutics (CAMP) Change in Accured Expenses (2023 - 2026)

Camp4 Therapeutics (CAMP) has 4 years of Change in Accured Expenses data on file, last reported at -$1.4 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Accured Expenses rose 50.86% year-over-year to -$1.4 million; the trailing twelve-month figure through Mar 2026 stood at $2.2 million (up 230.48% YoY), and the FY2025 full-year result was $805000.0, down 47.42% from the prior year.
• Change in Accured Expenses slipped to -$1.4 million in Q1 2026, from $1.2 million in the prior quarter.
• In the past five years, Change in Accured Expenses ranged from a high of $1.8 million in Q4 2024 to a low of -$2.8 million in Q1 2025.
• A 4-year average of $152900.0 and a median of $639500.0 in 2023 frame the typical range for Change in Accured Expenses.
• Across the five-year window, Change in Accured Expenses jumped 227.58% in 2024 and sank 721.88% in 2025, its largest moves.
• Tracing CAMP's Change in Accured Expenses over 4 years: stood at $562000.0 in 2023, then jumped by 227.58% to $1.8 million in 2024, then slumped by 34.93% to $1.2 million in 2025, then plunged by 214.27% to -$1.4 million in 2026.
• Business Quant data shows CAMP's Change in Accured Expenses at -$1.4 million in Q1 2026, $1.2 million in Q4 2025, and $1.4 million in Q3 2025.